LIOPF(LIOPF)
LIOPF
No analyst ratings available
No analyst price targets available for LIOPF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $443.45B | $449.02B | $461.38B | $474.26B | $484.61B |
| Low | $432.72B | $435.85B | $449.02B | $461.56B | $471.63B |
| High | $461.93B | $464.67B | $479.02B | $492.40B | $503.14B |
| EBITDA Avg | $58.21B | $58.94B | $60.56B | $62.25B | $63.61B |
| Low | $56.80B | $57.21B | $58.94B | $60.59B | $61.91B |
| High | $60.64B | $61.00B | $62.88B | $64.63B | $66.05B |
| EBIT Avg | $32.01B | $32.41B | $33.30B | $34.23B | $34.98B |
| Low | $31.23B | $31.46B | $32.41B | $33.31B | $34.04B |
| High | $33.34B | $33.54B | $34.57B | $35.54B | $36.31B |
| Net Income Avg | $25.61B | $27.02B | $29.68B | $31.01B | $32.88B |
| Low | $24.72B | $26.08B | $28.65B | $29.93B | $31.73B |
| High | $26.88B | $28.37B | $31.16B | $32.55B | $34.51B |
| EPS Avg | $92.50 | $97.60 | $107.21 | $112.01 | $118.75 |
| Low | $89.28 | $94.21 | $103.47 | $108.11 | $114.62 |
| High | $97.09 | $102.46 | $112.54 | $117.58 | $124.66 |
| Analysts (Rev / EPS) | 12 / 1 | 12 / 1 | 5 / 1 | 10 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $109.24B | $117.96B |
| Low | $106.64B | $113.82B |
| High | $114.46B | $120.14B |
| EBITDA Avg | $14.34B | $15.48B |
| Low | $14.00B | $14.94B |
| High | $15.03B | $15.77B |
| EBIT Avg | $7.88B | $8.51B |
| Low | $7.70B | $8.22B |
| High | $8.26B | $8.67B |
| Net Income Avg | $6.53B | $8.78B |
| Low | $6.28B | $8.44B |
| High | $6.81B | $9.15B |
| EPS Avg | $23.58 | $31.69 |
| Low | $22.67 | $30.47 |
| High | $24.58 | $33.03 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 |